Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guyana Health Review.
Press releases published on November 12, 2025
November 12, 2025
Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204
Indeterminate
GlobeNewswire
November 12, 2025
Aprea Therapeutics Reports Third quarter 2025 Financial Results and Provides a Clinical Update
Indeterminate
GlobeNewswire
November 12, 2025
Jushi Holdings Inc. Announces Grand Opening of Beyond Hello™ Little Ferry in New Jersey
Indeterminate
GlobeNewswire
November 12, 2025
Evaxion announce 2026 financial calendar
Indeterminate
GlobeNewswire
November 12, 2025
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
Indeterminate
GlobeNewswire
November 12, 2025
Collegium to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire
November 12, 2025
Essity Brand, JOBST®, Teams Up with Toronto Raptors to Prove that “Not All Armour is Made of Steel”
Indeterminate
GlobeNewswire
November 12, 2025
The C3i Center welcomes Bobby Boursiquot as its new Vice President of Commercialization
Indeterminate
GlobeNewswire
November 12, 2025
Le Centre C3i accueille Bobby Boursiquot en tant que nouveau vice-président chargé de la commercialisation
Indeterminate
GlobeNewswire
November 12, 2025
PMV Pharmaceuticals Reports Third Quarter 2025 Financial Results and Corporate Highlights
Indeterminate
GlobeNewswire
November 12, 2025
BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates
Indeterminate
GlobeNewswire
November 12, 2025
PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 12, 2025
Velocity Clinical Research Appoints Former Fortrea Executive, Andrew Reina, as Chief Revenue Officer
Indeterminate
GlobeNewswire
November 12, 2025
Zenas BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
November 12, 2025
Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
Indeterminate
GlobeNewswire
November 12, 2025
Monogram Health Announces New Executives to Oversee its U.S. Operations
Indeterminate
GlobeNewswire
November 12, 2025
Prelude Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire